2024 annual financial data
Harvard Bioscience 2024 Operating margin
Harvard Bioscience 2024 operating margin with verified reported values.
Direct answer
Operating margin was -6.6%.
Operating income was -6,211,000 USD and net income was -12,405,000 USD.
Operating cash flow was 1,440,000 USD.
Get free Harvard Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 94,135,000 USD
- Operating income
- -6,211,000 USD
- Net income
- -12,405,000 USD
- Operating cash flow
- 1,440,000 USD